NemazeeHospital.com

During the past 20 years we have had the pleasure of actively participating in what is now a fact clearly established: chronic infection by certain types of human papilloma virus (HPV) is the necessary cause for the development of cervical cancer. The application of prophylactic vaccines against HPV types most prevalent in cervical cancer will allow a drastic reduction of the disease in the space of 10-20 years, if these vaccines are given before contact with the virus, ie in the early teens and before first sex. These findings are the results of randomized clinical trials made public in the drug agency’s most influential and prestigious as the FDA or EMEA.

Recently, we read statements in the country in expressing some disappointment with the introduction of HPV vaccination in the Spanish population pressures on the Government claiming, non-emergency / urgent care due to illness, low efficiency of the vaccine and the need to improve Pap smear screening in before introducing an HPV vaccine (El Pais, August 30, 2007, September 11, 2007). All governments are under pressure to support or delay the introduction of new drugs and they are not specific vaccine in question here. The value of mass vaccination can not be dismissed simply by applying such pressure. The effectiveness of the vaccine is very high, exceeding 90%, if administered properly.

Comments are closed.